Portal de investigación
- Inicio
- Publicaciones
- Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine as conditioning regimen for matched sibling and unrelated donor transplant in patients with acute myeloid leukemia in fist complete remission. A study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine as conditioning regimen for matched sibling and unrelated donor transplant in patients with acute myeloid leukemia in fist complete remission. A study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Saraceni, F
- Labopin, M
- Hamladji, RM
- Mufti, G
- Socie, G
- Shimoni, A
- Delage, J
- Deconinck, E
- Chevallier, P
- Blaise, D
- Huynh, A
- Forcade, E
- Savani, B
- Mohty, M
- Nagler, A
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Saraceni,F,Labopin,M,Hamladji,RM,Mufti,G,Socie,G,Shimoni,A,Delage,J et al. Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine as conditioning regimen for matched sibling and unrelated donor transplant in patients with acute myeloid leukemia in fist complete remission. A study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT). 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). 2017. Marseille. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND:SPRINGERNATURE. 2017 p.p. 70-70.